Targeting and Blockades of Advanced and Metastatic Breast Cancer with Trispecific or Dual Bispecific Antibodies Non-Covalently Bound on Mpegylated Nanocarriers Loaded with Docetaxel and Pictilisib for Synergistic Therapy and Circumventing the Resistance(1/3)

Project: A - Government Institution › b - Ministry of Science and Technology

Project Details

StatusFinished
Effective start/end date8/1/18 → 7/31/19

Keywords

  • Trastuzumab
  • Pertuzumab
  • Pictilisib
  • Docetaxel
  • Anti-HER2IV/anti-mPEG Bispecific Antibody
  • Synergistic combination

Access Project